0000000000365500

AUTHOR

Sarah V. Biedermann

showing 5 related works from this author

Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-Arachidonoylglycerol in Humans

2017

Abstract Background Endocannabinoids are critical for rewarding behaviors such as eating, physical exercise, and social interaction. The role of endocannabinoids in mammalian sexual behavior has been suggested because of the influence of cannabinoid receptor agonists and antagonists on rodent sexual activity. However, the involvement of endocannabinoids in human sexual behavior has not been studied. Aim To investigate plasma endocannabinoid levels before and after masturbation in healthy male and female volunteers. Outcomes Plasma levels of the endocannabinoids 2-arachidonoylglycerol (2-AG), anandamide, the endocannabinoid-like lipids oleoyl ethanolamide and palmitoyl ethanolamide, arachido…

Male0301 basic medicinemedicine.medical_specialtyCannabinoid receptorPolyunsaturated AlkamidesUrologyEndocrinology Diabetes and MetabolismHuman sexual response cycleSexual arousalmedia_common.quotation_subject2-ArachidonoylglycerolOleic AcidsArachidonic AcidsOrgasmGlycerides03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInternal medicineCannabinoid Receptor ModulatorsmedicineHumansEthanolamideOrgasmmedia_commonCannabinoid Receptor AgonistsAnandamideEndocannabinoid systemMasturbationPsychiatry and Mental health030104 developmental biologyEndocrinologyReproductive MedicinechemistryFemalelipids (amino acids peptides and proteins)Psychologypsychological phenomena and processes030217 neurology & neurosurgeryEndocannabinoidsThe Journal of Sexual Medicine
researchProduct

Altered endocannabinoid-dynamics in craniopharyngioma patients and their association with HPA-axis disturbances.

2021

Objective Patients with craniopharyngioma (CP) frequently suffer from morbid obesity. Endocannabinoids (ECs) are involved in weight gain and rewarding behavior but have not been investigated in this context. Design Cross-sectional single-center study. Methods Eighteen patients with CP and 16 age- and sex-matched controls were included. Differences in endocannabinoids (2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (AEA)) and endocannabinoid-like molecules (oleoyl ethanolamide (OEA), palmitoylethanolamide (PEA), and arachidonic acid (AA) were measured at baseline and following endurance exercise. We further explored ECs-dynamics in relation to markers of HPA-axis activity (ACT…

AdultMalemedicine.medical_specialtyHypothalamo-Hypophyseal SystemHydrocortisonePolyunsaturated AlkamidesEndocrinology Diabetes and MetabolismHypothalamusContext (language use)Oleic AcidsArachidonic AcidsGlycerideschemistry.chemical_compoundCraniopharyngiomaYoung AdultEndocrinologyCopeptinAdrenocorticotropic HormoneEndurance trainingInternal medicinemedicineEthanolamideHumansPituitary NeoplasmsExerciseArachidonic Acidbusiness.industryGlycopeptidesGeneral MedicineMiddle Agedmedicine.diseaseEndocannabinoid systemCraniopharyngiomaEndurance TrainingEndocrinologyCross-Sectional StudieschemistryCase-Control StudiesArachidonic acidFemalemedicine.symptombusinessWeight gainEndocannabinoidsEuropean journal of endocrinology
researchProduct

Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids.

2016

Beneficial effects of voluntary wheel running on hippocampal neurogenesis, morphology and hippocampal-dependent behavior have widely been studied in rodents, but also serious side effects and similarities to stereotypy have been reported. Some mouse strains run excessively when equipped with running wheels, complicating the comparability to human exercise regimes. Here, we investigated how exercise restriction to 6h/day affects hippocampal morphology and metabolism, stereotypic and basal behaviors, as well as the endocannabinoid system in wheel running C57BL/6 mice; the strain most commonly used for behavioral analyses and psychiatric disease models. Restricted and unrestricted wheel runnin…

0301 basic medicineMaleBrain behaviorNeurogenesisHippocampal formationMotor ActivityHippocampusRunning03 medical and health sciencesBehavioral NeuroscienceMice0302 clinical medicineEndocrinologyPhysical Conditioning AnimalAerobic exerciseAnimalsHumansBehavior AnimalEndocrine and Autonomic SystemsNeurogenesisGlutamate receptorBrainEndocannabinoid systemMice Inbred C57BLStereotypy (non-human)030104 developmental biologyWheel runningStereotyped BehaviorPsychologyhuman activitiesNeuroscience030217 neurology & neurosurgeryEndocannabinoidsHormones and behavior
researchProduct

Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans

2021

Abstract A runner's high describes a sense of well-being during endurance exercise characterized by euphoria and anxiolysis. It has been a widespread belief that the release of endogenous opioids, such as endorphins, underlie a runner's high. However, exercise leads to the release of two classes of rewarding molecules, endocannabinoids (eCBs) and opioids. In mice, we have shown that core features of a runner's high depend on cannabinoid receptors but not opioid receptors. In the present study, we aimed to corroborate in humans that endorphins do not play a significant role in the underlying mechanism of a runner's high. Thus, we investigated whether the development of two core features of a…

medicine.medical_specialtyCannabinoid receptormedicine.drug_classEndocrinology Diabetes and MetabolismEuphoriantNaltrexoneRunningMice03 medical and health sciences0302 clinical medicineEndocrinologyOpioid receptorInternal medicineAnimalsHumansMedicineEndorphinsBiological PsychiatryEndogenous opioidEndocrine and Autonomic Systemsbusiness.industryEuphoria030227 psychiatryPsychiatry and Mental healthEndocrinologyOpioidAnxietyEndorphinsmedicine.symptombusinesshuman activities030217 neurology & neurosurgerymedicine.drugPsychoneuroendocrinology
researchProduct

Women with borderline personality disorder do not show altered BOLD responses during response inhibition.

2015

Impulsivity is central to borderline personality disorder (BPD). Response inhibition, addressing the ability to suppress or stop actions, is one aspect of behavioral impulse control which is frequently used to assess impulsivity. BPD patients display deficits in response inhibition under stress condition or negative emotions. We assessed whether response inhibition and its neural underpinnings are impaired in BPD when tested in an emotionally neutral setting and when co-morbid attention-deficit/hyperactivity disorder (ADHD) is excluded. To this end, we studied response inhibition in unmedicated BPD patients and healthy controls (HC) in two independent samples using functional magnetic reson…

Adultmedicine.medical_specialtyEmotionsNeuroscience (miscellaneous)AudiologyNeuropsychological TestsImpulsivitybehavioral disciplines and activitiesDevelopmental psychologyYoung AdultBorderline Personality Disordermental disordersmedicineControl networkReaction TimeHumansRadiology Nuclear Medicine and imagingYoung adultBorderline personality disorderResponse inhibitionIntelligence TestsIntelligence quotientmedicine.diagnostic_testMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingDisruptive Impulse Control and Conduct DisordersPsychiatry and Mental healthInhibition PsychologicalAttention Deficit Disorder with HyperactivityImpulsive BehaviorFemalemedicine.symptomPsychologyFunctional magnetic resonance imagingPsychomotor PerformancePsychiatry research
researchProduct